Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Vascular Biogenics (VBLT)
NASDAQ:VBLT
Holding VBLT?
Track your performance easily
VBLT Stock Chart & Stats
Day’s Range$0.15 - $0.19
52-Week Range― - ―
Previous Close$0.17
Volume5.65M
Average Volume (3M)N/A
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next Earnings
Nov 13, 2023EPS Estimate
-$0.41Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Vascular Biogenics News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
VBLT FAQ
What was Vascular Biogenics’s price range in the past 12 months?
Currently, no data Available
What is Vascular Biogenics’s market cap?
Currently, no data Available
When is Vascular Biogenics’s upcoming earnings report date?
Vascular Biogenics’s upcoming earnings report date is Nov 13, 2023 which is 375 days ago.
How were Vascular Biogenics’s earnings last quarter?
Vascular Biogenics released its earnings results on Aug 14, 2023. The company reported -$0.4 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.4.
Is Vascular Biogenics overvalued?
According to Wall Street analysts Vascular Biogenics’s price is currently Overvalued.
Does Vascular Biogenics pay dividends?
Vascular Biogenics does not currently pay dividends.
What is Vascular Biogenics’s EPS estimate?
Vascular Biogenics’s EPS estimate is -$0.41.
How many shares outstanding does Vascular Biogenics have?
Currently, no data Available
What happened to Vascular Biogenics’s price movement after its last earnings report?
Vascular Biogenics reported an EPS of -$0.4 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 3.478%.
Which hedge fund is a major shareholder of Vascular Biogenics?
Among the largest hedge funds holding Vascular Biogenics’s share is ARK Investment Management LLC. It holds Vascular Biogenics’s shares valued at N/A.
---
Vascular Biogenics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Company Description
Vascular Biogenics
Vascular Biogenics Ltd. is in the clinical-stage biopharmaceutical company, which engages in the discovery, development and commercialization of first-in-class treatments for cancer. It offers different programs for cancer and inflammatory disease patients such as vascular targeting system and Lecinoxoids. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel.
---
VBLT Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering VBLT
1 Year
1 Year Success Rate
0/0 ratings generated profit
1 Year Average Return
0.00%
initiated a buy rating a year ago
Copying Unknown Analyst's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of 0.00% per trade.
---